Nanovibronix Inc completed a merger with ENvue Medical Holdings on February 14, 2025, resulting in ENvue becoming a wholly-owned subsidiary and issuing shares that could lead to ENvue's holders owning up to 85% of Nanovibronix's common stock after stockholder approval.